HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases.

AbstractOBJECTIVES:
Autoantibodies to the dense fine speckled 70 (DFS70) antigen are common among antinuclear antibodies (ANA) positive healthy individuals (HI). We assessed the prevalence of anti-DFS70 antibodies in patients with and without ANA-associated rheumatic diseases (AARDs) by two methods: chemiluminescent immunoassay (CIA) and an indirect immunofluorescence (IIF) assay based on immunoadsorption for DFS70.
METHODS:
Fifty-one ANA-positive sera samples from patients with confirmed clinical diagnosis of AARD, 92 samples from HI and 85 samples submitted to a reference laboratory for routine ANA testing were evaluated for the presence of anti-DFS70 antibodies. The samples were evaluated by QUANTA Flash DFS70 CIA using BIO-FLASH instrument and by NOVA Lite selected HEp-2 kit on NOVA View - an automated IIF system. Sera with DFS positive pattern were pre-absorbed with highly purified human DFS70 antigen, and then tested again.
RESULTS:
Twenty-four samples (10.5%) tested by QUANTA Flash DFS70 CIA were positive for anti-DFS70 antibodies. The prevalence of monospecific anti-DFS70 antibodies was significantly higher in healthy subjects than in patients with AARDs (10.9% vs. 1.9%, p=0.02). The frequency of anti-DFS70 antibodies in samples submitted for routine ANA testing was 15.2%. A very good agreement was found between CIA and the DFS pattern identified by the automated HEp-2 IIF (kappa=0.97). In 80% of the samples obtained from patients without AARDs, immunoadsorption effectively inhibited the anti-DFS70 antibodies.
CONCLUSIONS:
The data confirm that mono-specific anti-DFS70 antibodies are a strong discriminator between ANA positive HI and AARD patients, and their evaluation should be included in ANA testing algorithms.
AuthorsOra Shovman, Boris Gilburd, Chen Chayat, Howard Amital, Pnina Langevitz, Abdulla Watad, Adi Guy, Dolores Perez, Danielle Azoulay, Miri Blank, Yael Segal, Chelsea Bentow, Michael Mahler, Yehuda Shoenfeld
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 2018 Jan-Feb Vol. 36 Issue 1 Pg. 121-126 ISSN: 0392-856X [Print] Italy
PMID28770702 (Publication Type: Journal Article)
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Antibodies, Antinuclear
  • Biomarkers
  • PSIP1 protein, human
  • Transcription Factors
Topics
  • Adaptor Proteins, Signal Transducing (immunology)
  • Antibodies, Antinuclear (blood)
  • Autoimmunity
  • Biomarkers (blood)
  • Case-Control Studies
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Immunoassay
  • Immunosorbent Techniques
  • Luminescent Measurements
  • Predictive Value of Tests
  • Reproducibility of Results
  • Rheumatic Diseases (blood, diagnosis, epidemiology, immunology)
  • Seroepidemiologic Studies
  • Transcription Factors (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: